Evidence map›Paper›PMID 22608499›Full record

ArticleAmerican journal of human genetics2012

Mutations of the mitochondrial-tRNA modifier MTO1 cause hypertrophic cardiomyopathy and lactic acidosis.

Daniele Ghezzi, Enrico Baruffini, Tobias B Haack, Federica Invernizzi, Laura Melchionda, Cristina Dallabona, Tim M Strom, Rossella Parini, Alberto B Burlina, Thomas Meitinger and 3 more

Open access · hybridAbstract read
In one paragraph

Article in American journal of human genetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 112 papers.

0numbers the graph read from it
0cells of the map it votes in
112citing papers in PubMed
8.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

112 citing papers in PubMed, 193 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Advances in RNA modification in myocardial fibrosis (Review).International journal of molecular medicine · 2025
    Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

52 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 2 countries.

Daniele GhezziUnit of Molecular Neurogenetics, Fondazione IRCCS, Milan, Italy.
Enrico Baruffini
Tobias B Haack
Federica Invernizzi
Laura Melchionda
Cristina Dallabona
Tim M Strom
Rossella Parini
Alberto B Burlina
Thomas Meitinger
Holger Prokisch
Ileana Ferrero
Massimo Zeviani
Helmholtz Zentrum München · DEIstituti di Ricovero e Cura a Carattere Scientifico · ITUniversity of Parma · ITFondazione IRCCS Istituto Neurologico Carlo Besta · ITTechnical University of Munich · DEUniversity of Milano-Bicocca · ITUniversity of Padua · IT

Funding

Telethon GGP11011
6 · The paper itself

Abstract

Dysfunction of mitochondrial respiration is an increasingly recognized cause of isolated hypertrophic cardiomyopathy. To gain insight into the genetic origin of this condition, we used next-generation exome sequencing to identify mutations in MTO1, which encodes mitochondrial translation optimization 1. Two affected siblings carried a maternal c.1858dup (p.Arg620Lysfs(∗)8) frameshift and a paternal c.1282G>A (p.Ala428Thr) missense mutation. A third unrelated individual was homozygous for the latter change. In both humans and yeast, MTO1 increases the accuracy and efficiency of mtDNA translation by catalyzing the 5-carboxymethylaminomethylation of the wobble uridine base in three mitochondrial tRNAs (mt-tRNAs). Accordingly, mutant muscle and fibroblasts showed variably combined reduction in mtDNA-dependent respiratory chain activities. Reduced respiration in mutant cells was corrected by expressing a wild-type MTO1 cDNA. Conversely, defective respiration of a yeast mto1Δ strain failed to be corrected by an Mto1(Pro622∗) variant, equivalent to human MTO1(Arg620Lysfs∗8), whereas incomplete correction was achieved by an Mto1(Ala431Thr) variant, corresponding to human MTO1(Ala428Thr). The respiratory yeast phenotype was dramatically worsened in stress conditions and in the presence of a paromomycin-resistant (P(R)) mitochondrial rRNA mutation. Lastly, in vivo mtDNA translation was impaired in the mutant yeast strains.

Indexed as

DNA Mutational AnalysisAcidosis, LacticBase SequenceCardiomyopathy, HypertrophicCarrier ProteinsDNA, MitochondrialFibroblastsHomozygoteHumansMitochondriaMolecular Sequence DataMothersMutationMutation, MissenseNucleic Acid ConformationOxidative PhosphorylationCarrier ProteinsDNA, MitochondrialMTO1 protein, humanParomomycinRNA-Binding ProteinsRNA, RibosomalRNA, Transfer

Identifiers

PMID22608499
PMCPMC3370278
OpenAlexW2079834131

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.